BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,029 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $202,000 | -35.7% | 2,517 | -35.4% | 0.01% | -28.6% |
| Q2 2021 | $314,000 | +53.9% | 3,895 | +61.2% | 0.01% | +40.0% |
| Q1 2021 | $204,000 | -11.3% | 2,417 | -9.6% | 0.01% | -44.4% |
| Q2 2020 | $230,000 | 0.0% | 2,675 | -5.5% | 0.01% | -30.8% |
| Q1 2020 | $230,000 | -13.2% | 2,831 | -10.6% | 0.01% | +8.3% |
| Q4 2019 | $265,000 | -6.4% | 3,167 | -2.2% | 0.01% | -20.0% |
| Q3 2019 | $283,000 | -4.1% | 3,237 | -10.2% | 0.02% | -6.2% |
| Q2 2019 | $295,000 | -9.0% | 3,603 | -9.7% | 0.02% | -5.9% |
| Q1 2019 | $324,000 | -0.6% | 3,988 | -20.5% | 0.02% | -26.1% |
| Q1 2018 | $326,000 | -3.3% | 5,015 | -3.8% | 0.02% | 0.0% |
| Q4 2017 | $337,000 | -2.0% | 5,215 | -5.0% | 0.02% | -14.8% |
| Q3 2017 | $344,000 | +3.6% | 5,490 | 0.0% | 0.03% | -6.9% |
| Q2 2017 | $332,000 | -0.9% | 5,490 | -14.9% | 0.03% | 0.0% |
| Q1 2017 | $335,000 | +50.2% | 6,455 | -4.9% | 0.03% | +26.1% |
| Q3 2015 | $223,000 | -49.9% | 6,791 | +6.8% | 0.02% | -46.5% |
| Q2 2015 | $445,000 | +20.6% | 6,359 | +18.0% | 0.04% | +19.4% |
| Q1 2015 | $369,000 | +59.1% | 5,391 | +70.5% | 0.04% | +56.5% |
| Q4 2014 | $232,000 | -69.5% | 3,162 | -70.2% | 0.02% | -70.1% |
| Q3 2014 | $760,000 | – | 10,594 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |